Creative Biolabs is the leading custom service provider with extensive experience in various antibody production and engineering fields.
The vector of anti-CD23 chimeric antigen receptor (CAR) is constructed for the engineering of T cells to target human CD23. The T cells are genetically modified through transduction with a lentiviral vector expressing scFv of anti-CD23 antibody linked to CD28 and CD3-zeta signaling domains. And the vector product was designed for the treatment of chronic lymphocytic leukemia (CLL).
Creative Biolabs is the leading custom service provider with extensive experience in various antibody production and engineering fields.